Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 20/20 | 0.73 |
| ▸ | CDK9 | P50750 | 20/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16050717 | 0.89 | CCNT1 (0.79) | CCNT1CDK9 | |
| SCHEMBL16051838 | 0.85 | CCNT1 (0.80) | CCNT1CDK9 | |
| SCHEMBL16041362 | 0.84 | CCNT1 (1.00) | CCNT1CDK9 | |
| SCHEMBL16051769 | 0.83 | CCNT1 (0.81) | CCNT1CDK9 | |
| SCHEMBL16050920 | 0.82 | CCNT1 (0.76) | CCNT1CDK9 | |
| SCHEMBL2087223 | 0.80 | CCNT1 (0.53) | CCNT1CDK9 | |
| SCHEMBL16052359 | 0.79 | CDK9 (1.00) | CCNT1CDK9 | |
| SCHEMBL16051379 | 0.79 | CCNT1 (1.00) | CCNT1CDK9 | |
| SCHEMBL16041400 | 0.78 | CCNT1 (1.00) | CCNT1CDK9 | |
| SCHEMBL17535072 | 0.78 | CCNT1 (1.00) | CCNT1CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970278-A1 | PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS | AbbVie Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014139328-A1 | PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS | ABBVIE INC. (US) | 2014-09-18 | — | — | WO | claimed |
| EP-2970278-A1 | PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS | AbbVie Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014139328-A1 | PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS | ABBVIE INC. (US) | 2014-09-18 | — | — | WO | disclosed |